Several factors have been associated with a higher risk of progression to multiple myeloma, including lesion size greater than 5 cm, age over 40 years, vertebral localization, and persistence of M-protein after treatment [3,7,13]. This evidence concerns the gene MYOM2 and AL amyloidosis.